Gene expression in early and progression phases of autosomal dominant polycystic kidney disease

被引:25
|
作者
Chen W.-C. [1 ,2 ]
Tzeng Y.-S. [1 ,2 ]
Li H. [1 ,2 ]
机构
[1] Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei 112
[2] Institute of Molecular Biology, Academia Sinica, Taipei 115
关键词
Autosomal Dominant Polycystic Kidney Disease; Kidney Volume; Autosomal Dominant Polycystic Kidney Disease Patient; Homozygous Mutant Mouse; Morphogenetic Signaling;
D O I
10.1186/1756-0500-1-131
中图分类号
学科分类号
摘要
Background. Little is known about the genes involved in the initial cyst formation and disease progression in autosomal dominant polycystic kidney disease (ADPKD); however, such knowledge is necessary to explore therapeutic avenues for this common inherited kidney disease. Findings. To uncover the genetic determinants and molecular mechanisms of ADPKD, we analyzed 4-point time-series DNA microarrays from Pkd1L3/L3 mice to generate high resolution gene expression profiles at different stages of disease progression. We found different characteristic gene expression signatures in the kidneys of Pkd1L3/L3 mice compared to age-matched controls during the initial phase of the disease. By postnatal week 1, the Pkd1L3/L3 kidney already had a distinctive gene expression pattern different from the corresponding normal controls. Conclusion. The genes differentially expressed, either induced or repressed, in ADPKD are important in immune defense, cell structure and motility, cellular proliferation, apoptosis and metabolic processes, and include members of three pathways (Wnt, Notch, and BMP) involved in morphogenetic signaling. Further analysis of the gene expression profiles from the early stage of cystogenesis to end stage disease identified a possible gene network involved in the pathogenesis of ADPKD. © 2008 Li et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [41] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Pljesa, Steva
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 : 340 - 347
  • [42] Autosomal Dominant Polycystic Kidney Disease
    Pei, York
    Watnick, Terry
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (02) : 115 - 117
  • [43] Autosomal dominant polycystic kidney disease
    Cornec-Le Gall, Emilie
    Alam, Ahsan
    Perrone, Ronald D.
    [J]. LANCET, 2019, 393 (10174): : 919 - 935
  • [44] Autosomal dominant polycystic kidney disease
    Pirson, Y
    Chauveau, D
    Watson, ML
    Zeier, M
    Breuning, MH
    [J]. M S-MEDECINE SCIENCES, 1997, 13 (01): : 37 - 44
  • [45] Autosomal dominant polycystic kidney disease
    Beebe, DK
    [J]. AMERICAN FAMILY PHYSICIAN, 1996, 53 (03) : 925 - 931
  • [46] Autosomal dominant polycystic kidney disease
    Torres, Vicente E.
    Harris, Peter C.
    Pirson, Yves
    [J]. LANCET, 2007, 369 (9569): : 1287 - 1301
  • [47] HUNT FOR THE DOMINANT AUTOSOMAL POLYCYSTIC KIDNEY-DISEASE GENE
    BACHNER, L
    [J]. M S-MEDECINE SCIENCES, 1990, 6 (09): : 904 - 905
  • [48] Autosomal dominant polycystic kidney disease
    Torres, VE
    Harris, PC
    [J]. NEFROLOGIA, 2003, 23 : 14 - 22
  • [49] Autosomal dominant polycystic kidney disease
    Grantham, Jared J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (14): : 1477 - 1485
  • [50] Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease
    Xu, Yuchen
    Li, Ao
    Wu, Guanqing
    Liang, Chaozhao
    [J]. CURRENT GENE THERAPY, 2017, 17 (01) : 43 - 49